Viatris Inc.
$32.48B- Market cap
- $19.39B
- Debt
- +$14.41B
- Cash
- −$1.32B
Capital structure 57% equity / 43% debt · EV / Revenue 2.27x · EV / EBITDA 1393.83x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $19.39B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2024 · View financials
Decision snapshot: VTRS stock price vs HBI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HBI's multiple
Needs HBI P/S.
Implied fair value · at VTRS's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: VTRS FY 2025 (ended Dec 31, 2025) · HBI FY 2024 (ended Dec 28, 2024). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 57% equity / 43% debt · EV / Revenue 2.27x · EV / EBITDA 1393.83x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
VIATRIS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Hanesbrands Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.98x
67.07x
Net debt / EBITDA
Leverage against operating earnings
561.72x
-9.84x
Cash and equivalents
Liquid reserves on the balance sheet
$1.32B
$214.85M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
VTRS vs PFE
Organon & Co.
VTRS vs OGN
BRISTOL MYERS SQUIBB CO
VTRS vs BMY
AbbVie Inc.
VTRS vs ABBV
Merck & Co., Inc.
VTRS vs MRK
G III APPAREL GROUP LTD /DE/
VTRS vs GIII
SKECHERS USA INC
VTRS vs SKX
Kontoor Brands, Inc.
VTRS vs KTB
Under Armour, Inc.
VTRS vs UAA
COLUMBIA SPORTSWEAR CO
VTRS vs COLM
$14.41B
$2.28B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.